Publication:


abstract

INTRODUCTION:

Hering's 'Law of Cure' is considered important in homeopathy and thought to predict a positive outcome to treatment. No formal outcome measures are currently available to monitor response to homeopathic treatment on the basis of these assumptions. We describe a simple Assessment Tool, the Hering's Law Assessment Tool (HELAT) to identify and differentiate patient responses to homeopathic treatment as corresponding to Hering's Law from other symptomatic responses. We describe the Development of the tool and assess its face, content and predictive validity.

METHOD:

The HELAT was initially developed through literature review, discussion between homeopaths and clinical experience. In phase one, the tool was reviewed by three experienced homeopaths to assess face and content validity. In phase two, we tested its predictive validity by hypothesizing that the HELAT total score may predict changes in a clinical response (using standard validated rheumatological outcome, the American College of Rheumatology (ACR)20%) in 32 patients with rheumatoid arthritis receiving homeopathic intervention over 24 weeks as part of a clinical trial.

RESULTS:

The HELAT was piloted and changed to improve face and content validity and the final version was then employed for phase two as a predictor of outcome. HELAT total score predicted patient's clinical response (ACR20) [B = 1.142, SE = 0.462, P = 0.013] which was independent of practitioner assessing the patients treatment response [B = 1.04, SE = 1.01, P = 0.302].

CONCLUSION:

The initial data suggests that the HELAT may hold promise for a potential clinical and research outcome measure in homeopathy. Further work is now needed to formally assess its reliability and validity for potential use in clinical practice and trials.

Copyright © 2011 The Faculty of Homeopathy. Published by Elsevier Ltd. All rights reserved.

Related Articles
Homeopathy has clinical benefits in rheumatoid arthritis patients that are attributable to the consultation process but not the homeopathic remedy: a randomized controlled clinical trial.
Rheumatology (Oxford). 2011
Homeopathy has clinical benefits in rheumatoid arthritis patients that are attributable to the consultation process but not the homeopathic remedy: a randomized controlled clinical trial.
Brien S, Lachance L, Prescott P, McDermott C, Lewith G. Rheumatology (Oxford). 2011 Jun; 50(6):1070-82. Epub 2010 Nov 13.
The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials.
Arthritis Rheum. 1993
The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials.
Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, Furst D, Goldsmith C, Kieszak S, Lightfoot R. Arthritis Rheum. 1993 Jun; 36(6):729-40.
A proposed revision to the ACR20: the hybrid measure of American College of Rheumatology response.
Arthritis Rheum. 2007
A proposed revision to the ACR20: the hybrid measure of American College of Rheumatology response.
American College of Rheumatology Committee to Reevaluate Improvement Criteria. Arthritis Rheum. 2007 Mar 15; 57(2):193-202.
Review The American College of Rheumatology (ACR) Core Data Set and derivative "patient only" indices to assess rheumatoid arthritis.
Clin Exp Rheumatol. 2005
Review The American College of Rheumatology (ACR) Core Data Set and derivative "patient only" indices to assess rheumatoid arthritis.
Pincus T. Clin Exp Rheumatol. 2005 Sep-Oct; 23(5 Suppl 39):S109-13.
Review Homeopathy.
Med Clin North Am. 2002
Review Homeopathy.
Merrell WC, Shalts E. Med Clin North Am. 2002 Jan; 86(1):47-62.